Cargando…
SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022)
Colorectal cancer (CRC) is the second leading cause of cancer deaths in Spain. Metastatic disease is present in 15–30% of patients at diagnosis and up to 20–50% of those with initially localized disease eventually develop metastases. Recent scientific knowledge acknowledges that this is a clinically...
Autores principales: | Fernández Montes, Ana, Alonso, Vicente, Aranda, Enrique, Élez, Elena, García Alfonso, Pilar, Grávalos, Cristina, Maurel, Joan, Vera, Ruth, Vidal, Rosario, Aparicio, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425293/ https://www.ncbi.nlm.nih.gov/pubmed/37133732 http://dx.doi.org/10.1007/s12094-023-03199-1 |
Ejemplares similares
-
SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021)
por: Capdevila, Jaume, et al.
Publicado: (2022) -
SEOM-GEMCAD-TTD Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021)
por: Fernández-Montes, Ana, et al.
Publicado: (2022) -
Correction to: SEOM‑GEMCAD‑TTD clinical guidelines for localized rectal cancer (2021)
por: Capdevila, Jaume, et al.
Publicado: (2022) -
SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015
por: Aranda, E., et al.
Publicado: (2015) -
SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018)
por: Gómez-España, M. A., et al.
Publicado: (2018)